Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc. | Chief Medical Officer | Common Stock | 10.7K | $96.2K | $8.96 | Aug 5, 2024 | Direct |
Sage Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 22.5K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc. | Aug 5, 2024 | 2 | -$29.5K | 4 | Aug 7, 2024 | Chief Medical Officer |
SAGE | Sage Therapeutics, Inc. | Feb 13, 2024 | 2 | $0 | 4 | Feb 15, 2024 | Chief Medical Officer |
SAGE | Sage Therapeutics, Inc. | Feb 13, 2023 | 1 | $0 | 4 | Feb 15, 2023 | Chief Medical Officer |
SAGE | Sage Therapeutics, Inc. | Nov 1, 2022 | 1 | $0 | 4 | Nov 1, 2022 | Chief Medical Officer |
SAGE | Sage Therapeutics, Inc. | Oct 31, 2022 | 0 | $0 | 3 | Nov 1, 2022 | Chief Medical Officer |